← USPTO Patent Grants

GLP-1 agonist polypeptide compound and salt thereof, synthesis method therefor and use thereof

Grant US12590134B2 Kind: B2 Mar 31, 2026

Assignee

SINOPEP-ALLSINO BIOPHARMACEUTICAL CO., LTD.

Inventors

Chengqing Zhao, Guoqiang Shi, Shunzi Li, Caidian Wang

Abstract

The disclosure provides a GLP-1 agonist polypeptide compound having an amino acid sequence: H Xaa1EGTFTSDVSSYLE Xaa2QAA Xaa3EFIAWLVRGRG (SEQ ID NO: 1). The C-terminal amino acid of the polypeptide compound is a carboxyl or the carboxyl is amidated. Xaa1 and Xaa2 are the same or different; R1 is: a straight-chain or branched-chain alkyl containing 2-6 carbon atoms, R2 is: H or CH3, X is: O, S or N—CH3, in the formula, R1 and R2 alkyl is optionally substituted by 1-6 halogen atoms.

CPC Classifications

C07K 14/605 C07K 14/001 A61K 38/00 A61P 3/04 A61P 3/10

Filing Date

2022-08-17

Application No.

17820251

Claims

2